LifeVantage (NASDAQ:LFVN) announced its quarterly earnings results on Wednesday. The company reported $0.13 earnings per share (EPS) for the quarter, reports. LifeVantage had a net margin of 0.66% and a return on equity of 23.55%.
Shares of LifeVantage stock opened at $4.00 on Thursday. The stock has a market cap of $57.26 million, a PE ratio of 16.79 and a beta of 0.47. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.55 and a quick ratio of 0.81.
LifeVantage Corporation identifies, researches, develops, and distributes nutraceutical dietary supplements and skin care products. It offers Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skin care product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Petandim for Dogs, a companion pet supplement formulated to combat oxidative stress in dogs.
Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.